PhocaX
Start a conversation

Peptide discovery + delivery · AI-enabled · early stage

Building better ways to deliver peptide therapeutics.

PhocaX combines peptide and delivery-system thinking with AI-supported evidence mapping and expert-owned program decisions—building toward medicines that can clear the path from scientific promise to practical product evidence.

PhocaX is early stage. We do not have a clinical-stage pipeline, an approved product, or evidence of safety or effectiveness in patients.

Our mission

Make peptide medicines easier to deliver—and faster to advance.

PhocaX is building an AI-enabled biotechnology company focused on peptide discovery and delivery. We design around stability, exposure, route, manufacturability, usability, and safety from the beginning—then generate the evidence needed to advance the strongest programs.

See the company and milestone model
  1. 01
    Better therapeutic opportunities

    Discover differentiated peptide programs built around meaningful biology and clear patient needs.

  2. 02
    Better delivery

    Design the peptide, formulation, route, and use experience as one medicine—not disconnected steps.

  3. 03
    Faster, safer decisions

    Use AI-supported research and decisive experiments to learn earlier, reduce avoidable risk, and fund what earns the next step.

Two ideas guide the company

The science we want to improve—and how we plan to do the work.

Ways we can help right now

What are you trying to get done?

For scientific and capital partners

Fund the next decision—not the story around it.

PhocaX is looking for collaborators, advisors, and aligned investors who understand that peptide delivery becomes valuable only when biology, formulation, manufacturability, safety, and a real product path are tested together.

Review the company and milestone model

Build with PhocaX

Better peptide medicines will take the right people working together.

We want to meet scientists, delivery and formulation experts, CRO/CDMO teams, advisors, and investors who care about better peptide medicines and honest evidence.

Start a conversation See current services